Pentoxifylline
- TRADE NAMES: Apo-Pentoxifylline; Artal; Azupentat; Elorgan; Hemovas; Pentoxi; Pentoxil (Upsher-Smith); Pexal; Torental; Trental (Sanofi-Aventis)
- INDICATIONS: Peripheral vascular disease, intermittent claudication
- CLASS: Vasodilator, peripheral, Xanthine alkaloid
- HALF-LIFE: 0.4–0.8 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Abciximab, Benazepril, Captopril, Ceftobiprole, Cilostazol, Ciprofloxacin, Citalopram, Clevidipine, Clopidogrel, Diclofenac, Enalapril, Eptifibatide, Fosinopril, Insulin Degludec, Insulin Glargine, Insulin Glulisine, Irbesartan, Lisinopril, Meloxicam, Olmesartan, Quinapril, Ramipril, Tinzaparin
PREGNANCY CATEGORY: C
Please login to see the rest of this drug profile
SKIN.
NAILS.
MUCOSAL.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
GASTROINTESTINAL/HEPATIC.
HEMATOLOGIC.
RESPIRATORY.
OTHER.
Page last updated 07/31/2023
Symbol key
Incidence 
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Seriousness
- Hospitalization possible
- Life threatening
- Fatal
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric
